Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Publikováno v:
Value in Health
Objectives We applied principles for conducting economic evaluations of factorial trials to a trial-based economic evaluation of a cluster-randomized 2 × 2 × 2 factorial trial. We assessed the cost-effectiveness of atorvastatin, omega-3 fish oil, a
Autor:
Curtis D. Collins, Ann K. Schwemm
Publikováno v:
Value in Health. 18(5):614-621
Objective To examine the cost-effectiveness of vancomycin versus linezolid in the empiric treatment of nosocomial pneumonias incorporating results from a recent prospective, double-blind, multicenter, controlled trial in adults with suspected methici
Publikováno v:
Value in Health. 13:543-551
OBJECTIVES: To estimate the cost-effectiveness of topical intranasal steroids for the treatment of otitis media with effusion (OME) in primary care from the perspective of the UK National Health Service. METHODS: An economic evaluation was conducted
Publikováno v:
Value in Health. 12:649-656
Background There is only limited information about cost-effectiveness of drug-eluting compared with bare metal stents (BMS) over a time horizon of more than 1 year. Methods and Results We developed a Markov model based on clinical outcome data from a
Autor:
William F. McGhan
Publikováno v:
Value in Health. 4:97-98
Peripheral artery disease manifests as intermittent claudication in over 4 million people in the US. In people older than 60 years, intermittent claudication occurs in 5% of men and 3% of women. OBJECTIVES: The purpose of this study was to develop a
Publikováno v:
Value in Health. (5):652-656
Objective A head-to-head comparator study has shown that the clinical efficacy of ustekinumab is superior to that of etanercept over a 12-week period in patients with psoriasis. Economic models are often hindered by the lack of trials directly compar
Autor:
Peter Lindgren, Hans-Christoph Diener, Joachim Schrader, Wolfgang Greiner, Birgit Gradl, Stephan Lüders, Björn Schwander, York Zöllner, Bengt Jönsson, Fernando Antoñanzas Villar
Publikováno v:
RIUR. Repositorio Institucional de la Universidad de La Rioja
instname
RIUR: Repositorio Institucional de la Universidad de La Rioja
Universidad de La Rioja (UR)
instname
RIUR: Repositorio Institucional de la Universidad de La Rioja
Universidad de La Rioja (UR)
Objective: To investigate the cost-utility of eprosartan versus enalapril (primary prevention) and versus nitrendipine (secondary prevention) on the basis of head-to-head evidence from randomized controlled trials. Methods: The HEALTH model (Health E
Publikováno v:
Value in Health. (2):149
OBJECTIVE: Comparative cost-effectiveness was assessed in an open-label, randomized trial (QUEST) that compared the efficacy and safety of quetiapine with risperidone in a outpatient population with schizophrenia or other psychotic disorders. METHOD: